Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review
Oncology Research · 2026
DOI: 10.32604/or.2025.070523 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Oncology Research, 2026. Verfasst von Giacomo Iovane und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, University Hospital of Parma, Parma, 43126, Italy. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Quinolines, Everolimus, Immune Checkpoint Inhibitors. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology Unit, University Hospital of Parma, Parma, 43126, Italy.
- Medical Oncology Unit, University Hospital of Genova, Genova, 16132, Italy.
- Medical Oncology Unit, Portsmouth Hospitals University NHS Trust, Portsmouth, PO6 3LY, UK.
- Pathology Unit, University Hospital of Parma, Parma, 43126, Italy.
- Medical Oncology Unit, Hospital of Macerata, Macerata, 62100, Italy.
Zitieren
APA
Iovane, G., Traman, L., Maffezzoli, M., Fornarini, G., Corradi, D., Guareschi, D., Santoni, M., & Buti, S. (2026). Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review. Oncology Research. https://doi.org/10.32604/or.2025.070523
Vancouver
Iovane G, Traman L, Maffezzoli M, Fornarini G, Corradi D, Guareschi D, et al. Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review. Oncology Research. 2026. doi:10.32604/or.2025.070523
BibTeX
@article{Iovane2026,
author = {Iovane, Giacomo and Traman, Luca and Maffezzoli, Michele and Fornarini, Giuseppe and Corradi, Domenico and Guareschi, Debora and Santoni, Matteo and Buti, Sebastiano},
title = {Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2025.070523}
}
EUVIMED